Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Illumina for Startups Home

Perspectives Blog

2 min read
Illumina’s Diversity, Equity, and Inclusion Actions Earn External Recognition and Further Advance Our Culture of Care
By Dr. Lisa Toppin , Global Head of Diversity and Inclusion 27 January 2022
4 min read
2021 in Genomics
By Francis deSouza , CEO
30 December 2021
2 min read
When it Comes to Diversity, Awareness is No Longer Enough
By Dr. Lisa Toppin , Global Head of Diversity and Inclusion
6 October 2021
2 min read
Empowering Informed Choices That Can Change Lives
By Gretchen Weightman , General Manager — Asia Pacific & Japan
30 June 2021
3 min read
Reflections on a Long-term Collaboration to Drive Rapid Whole Genome Diagnostics
By Kevin Hall, Senior Director, Development 16 June 2021
3 min read
Security and Scale in The Era of Genomics Data Discovery
By Susan Tousi, Chief Commercial Officer 8 June 2021
3 min read
Solving for the Information Gap in Genomics Breakthroughs
By Hans Cobben, VP, Software Development 28 January 2021
1 min read
MLK Day 2021: Turning Hope into Action
By Dr. Lisa Toppin, VP, Diversity and Inclusion 14 January 2021
11 min read
2020 in genomics: a global pandemic and groundbreaking scientific developments
By Francis deSouza, CEO 13 December 2020
4 min read
Reflecting on the Human Genome Project
By Susan Tousi, SVP, CPO 26 October 2020
1 min read
More expectant parents to get access to non-invasive prenatal testing
By Dr. Phil Febbo, SVP, CMO 9 October 2020
6 min read
Illumina's COVID testing service
By Dr. Phil Febbo, SVP, CMO 3 September 2020
2 min read
Every voice raised against racism chips away at its power
By Francis deSouza, CEO 30 June 2020
3 min read
Illumina and BlueBee: Unlocking the full potential of genomic insights
By Susan Tousi, SVP, CPO 18 June 2020
2 min read
Illumina receives first FDA emergency use authorization for a sequencing based COVID-19 diagnostic test
By Susan Tousi, SVP, CPO 9 June 2020
3 min read
The role of genomics in the COVID-19 pandemic, today and in the future
By Dr. Phil Febbo, SVP, CMO 8 June 2020
2 min read
Standing up and speaking out for equality and justice
By Susan Tousi, SVP, CPO 3 June 2020
4 min read
Something to roar about
By Susan Tousi, SVP, CPO 19 May 2020
2 min read
DNA Day in the time of COVID-19
By Francis deSouza, CEO 25 April 2020
2 min read
Delivering world-class solutions to combat COVID-19
By Susan Tousi, SVP, CPO 16 April 2020
5 min read
How sequencing-based surveillance helps fight COVID-19
By Dr. Phil Febbo, SVP, CMO 31 March 2020
2 min read
Why You Should Care about Rare Disease Day
By Francis deSouza, CEO 24 February 2020
3 min read
Helping the heroes on the front lines of the SARS-CoV-2 battle
By Francis deSouza, CEO 18 February 2020
2 min read
How sequencing helps solve the "unknown" of novel viral outbreaks
By Francis deSouza, CEO 13 February 2020
4 min read
Partnerships catalyze patient access to genomic testing
By Dr. Phil Febbo, SVP, CMO 13 January 2020
5 min read
The power and promise of liquid biopsies
By Dr. Phil Febbo, SVP, CMO 6 November 2019
5 min read
The complex world of pan-cancer biomarkers
By Dr. Phil Febbo, SVP, CMO 26 September 2019

Driving innovation for a healthy future

@illumina

In the News

Date Publication Title
20 Mar 2023 CNN International 100,000 newborn babies will have their genomes sequenced in the UK. It could have big implications for child medicine
14 Mar 2023 TechnologieBox CeGaT is one of the first companies worldwide to receive the most powerful sequencing platform NovaSeq™ X Plus
8 Mar 2023 Diagnostics World Illumina, Myriad Partner To Release HRD Test
View All Illumina News
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2023 Illumina, Inc. All rights reserved.